Copyright ©Hymerney Pharmaceutical Co., Ltd..
●Eight kinds of Hemony products were listed in the new edition of National Basic Medical Insurance, Industrial Injury Insurance and Maternity Insurance Medicines;Eight kinds of Hemony products were listed in the new edition of National Basic Medical Insurance, Industrial Injury Insurance and Maternity Insurance Medicines;
●"Consistency Evaluation of Calcium carbonate (CaCO3) D3 chewable tablet" was approved as the Special Project of Technological Innovation and Application Development in Chongqing.
● Obtained the pharmaceutical certificate rights of Martner (multivitamin formula with minerals (23)) produced by Wyeth Nutrition (China) Co., Ltd. in China.
●Appraised as Safety Production Standardization Enterprise of Level Three (for light industry and other);
●The Chongqing Headquarter was smoothly relocated to the Hemony Technological Park;
●Rated as "Professional, Fined, Unique and Innovative" Small and Medium Enterprise in Chongqing after being identified by Chongqing Small and Medium Enterprise Bureau;
●Procured all rights of Lioresal (baclofen) of Novartis.
●Got the exclusive distributorship of Alpha-Lipon (Thioctic Acid Injection) produced by German stada in China.
●Procured all rights of Trazodone Hydrochloride Tablets (Baclofen tablets) of Lotus Pharms Inc.
●Procured all rights of Calcichew D (Calcium carbonate (CaCO3) D3 chewable tablet) and Calcichew (Calcium carbonate (CaCO3) chewable tablet) of Shanghai General Parmaceutical Co., Ltd.
●Procured all rights of propylthiouracil of Herbrand Pharma Chemicals GmbH;
●Completed shareholding reform, set "Hemony Pharmaceutical Co., Ltd.".
●Procured all rights of Beishounin (budesonide Nasal spray) of Synmosa Biopharma Corporation;
●Procured all rights of Baclofen (Baclofen tablets) of Taiwan Weidar Chem & Pharm Co., Ltd. and commercial rights of Seradase (Enteric-coated Tablets) in mainland.
●Procured all rights of Calcitriol Soft Capsules produced by Chin Teng International Pharmaceutical Manufacture Corp.
●Chongqing Hemony Pharmaceutical Co., Ltd. obtained GMP certificate and put into product formally;
●Merged and acquired famous Chinese company - "Beijing MDC” to arrange direct sales nationwide;
●Obtained the master resell right of Cefobid (cefoperazone sodium for ejection) produced by Pfizer in China.
●Established "Hemony Pharmaceutical Co., Ltd." and built a holding platform.
●Obtained the master resell right of Jisuxing (Gemifloxacin mesylate) of Kerea LG Chemical in China.
●Merged and acquired "Qinghai Junzha Pharmaceutical Co., Ltd." and enter the pharmaceutical industry.
●Set Chongqing Hemony Pharmaceutical Co., Ltd. (previously the Chongqing Hua Chang Pharmaceutical Co., Ltd.). Started the relocation of Qinghai Junzha Pharmaceutical Co., Ltd. to Chongqing and initiated the construction of R&D and production base.
●Kaiyu Pharmaceutical was established to sell domestic drugs in Chongqing.